Development of innovative antimicrobials against pathogens resistant to antimicrobials[E8]

Del anuncio

Call: Cluster 1 - Health (Single stage - 2027/1). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The scientific and clinical communities have a better understanding of and access to new and innovative products for the treatment of antimicrobial resistant bacteria and fungi, as well as for further clinical investigation. Candidate therapies are available to treat patients for antimicrobial resistant bacteria and fungi, increasing therapeutic options for clinical deployment in the fight against Antimicrobial Resistance (AMR). Scope: The rapid rise of AMR presents a formidable threat to public health, challenging our ability to treat infections that were once easily managed with standard antimicrobials. As pathogens continually adapt and develop resistance to existing drugs, the efficacy of these treatments diminishes, leading to more severe and prolonged illnesses, increased healthcare costs and productivity losses, and higher mortality rates. This escalating crisis underscores an urgent need for viable therapeutic alternatives required to reduce the burden of diseases caused by antibiotic resistance. Innovative solutions are crucial to maintaining effective disease management and safeguarding public health. Propos…[E3]

Los datos del anuncio se muestran tal como los publicó la fuente. Los datos y requisitos que extraemos están en inglés.

• Abierta aUniversities and research. Etiquetado por SLETOR a partir del texto de la convocatoria.
• CondiciónEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RiesgoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• DesconocidoWe read the funder's listing, not the full guidance or application forms.

1. Abierta a ofertas · 29 oct 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Cambios: status, notice type, published at (registro de origen Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08))

2. Vista por primera vez · 28 oct 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Registro de origen: Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08)

Cada dato de esta página procede de la convocatoria del financiador. Cada entrada muestra el registro y el campo del que se leyó.

1. E1

   The funder is European Commission.

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/type/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/deadlineDate/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed…”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/descriptionByte/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/type/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

5. E5

   This is an EU call for proposals.

   “31094502”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/status/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/startDate/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/status/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

8. E8

   The notice is titled "Development of innovative antimicrobials against pathogens resistant to antimicrobials".

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/title/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

9. E9

   The EU contribution per grant is up to EUR 11,000,000 (from EUR 3,000,000).

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/budgetOverview/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Licencia de datos: Creative Commons Attribution 4.0 (European Commission) ↗ (se abre en una pestaña nueva). No guardamos ni mostramos los datos de contacto personales de los anuncios.